JPMorgan Chase & Co’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.43M Sell
909,436
-53,098
-6% -$200K ﹤0.01% 2976
2025
Q1
$4.36M Sell
962,534
-276,082
-22% -$1.25M ﹤0.01% 2759
2024
Q4
$8.76M Sell
1,238,616
-62,565
-5% -$442K ﹤0.01% 2340
2024
Q3
$10.6M Buy
1,301,181
+119,078
+10% +$969K ﹤0.01% 2124
2024
Q2
$7.55M Buy
1,182,103
+212,939
+22% +$1.36M ﹤0.01% 2284
2024
Q1
$7.3M Sell
969,164
-121,685
-11% -$916K ﹤0.01% 2330
2023
Q4
$10.1M Sell
1,090,849
-888,612
-45% -$8.23M ﹤0.01% 2103
2023
Q3
$20M Sell
1,979,461
-125,663
-6% -$1.27M ﹤0.01% 1510
2023
Q2
$26.3M Buy
2,105,124
+242,609
+13% +$3.03M ﹤0.01% 1377
2023
Q1
$21.7M Sell
1,862,515
-505,371
-21% -$5.9M ﹤0.01% 1421
2022
Q4
$25.2M Buy
2,367,886
+938,440
+66% +$9.98M ﹤0.01% 1282
2022
Q3
$13.9M Buy
1,429,446
+1,142,719
+399% +$11.1M ﹤0.01% 1654
2022
Q2
$4.15M Buy
286,727
+161,072
+128% +$2.33M ﹤0.01% 2527
2022
Q1
$3.28M Buy
125,655
+44,843
+55% +$1.17M ﹤0.01% 2847
2021
Q4
$3.2M Buy
80,812
+39,919
+98% +$1.58M ﹤0.01% 2879
2021
Q3
$2.05M Buy
40,893
+14,667
+56% +$733K ﹤0.01% 3168
2021
Q2
$1.46M Sell
26,226
-7,399
-22% -$410K ﹤0.01% 3412
2021
Q1
$1.57M Sell
33,625
-19,039
-36% -$890K ﹤0.01% 3377
2020
Q4
$2.29M Sell
52,664
-4,265
-7% -$186K ﹤0.01% 2883
2020
Q3
$2.09M Buy
56,929
+30,463
+115% +$1.12M ﹤0.01% 2721
2020
Q2
$773K Sell
26,466
-188,104
-88% -$5.49M ﹤0.01% 3132
2020
Q1
$5.61M Buy
214,570
+199,032
+1,281% +$5.2M ﹤0.01% 1915
2019
Q4
$539K Buy
15,538
+12,876
+484% +$447K ﹤0.01% 3386
2019
Q3
$84K Buy
+2,662
New +$84K ﹤0.01% 4057